CEO decision date.

No definition available.

Name:	gnft_CEODecisionDate
Namespace Prefix:	gnft_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Date of decision and delegation of Board of Directors to CEO.

+ References

No definition available.

+ Details

Name:	gnft_DateOfDecisionAndDelegationOfBoardOfDirectorsToCEO
Namespace Prefix:	gnft_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Description of exercise period for share based payment arrangement.

+ References

No definition available.

+ Details

Name:	gnft_DescriptionOfExercisePeriodForShareBasedPaymentArrangement
Namespace Prefix:	gnft_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of share options share based payment arrangement.

+ References

No definition available.

+ Details

Name:	gnft_FairValueOfShareOptionsShareBasedPaymentArrangement
Namespace Prefix:	gnft_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Management board meeting date.

+ References

No definition available.

+ Details

Name:	gnft_ManagementBoardMeetingDate
Namespace Prefix:	gnft_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of share options subscribed in share based payment arrangement.

+ References

No definition available.

+ Details

Name:	gnft_NumberOfShareOptionsSubscribedInShareBasedPaymentArrangement
Namespace Prefix:	gnft_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of share options vested share based payment arrangement.

+ References

No definition available.

+ Details

Name:	gnft_NumberOfShareOptionsVestedShareBasedPaymentArrangement
Namespace Prefix:	gnft_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of shares at allocation.

+ References

No definition available.

+ Details

Name:	gnft_PriceOfSharesAtAllocation
Namespace Prefix:	gnft_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Shareholder meeting date.

+ References

No definition available.

+ Details

Name:	gnft_ShareholderMeetingDate
Namespace Prefix:	gnft_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Turnover rate share warrants granted.

+ References

No definition available.

+ Details

Name:	gnft_TurnoverRateShareWarrantsGranted
Namespace Prefix:	gnft_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Valuation method used in share based payment arrangements.

+ References

No definition available.

+ Details

Name:	gnft_ValuationMethodUsedInShareBasedPaymentArrangements
Namespace Prefix:	gnft_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]

+ References

+ Details

Name:	ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_a&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The exercise price of share options granted.

+ References

+ Details

Name:	ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix:	ifrs-full_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of an expected dividend used to calculate the fair value of share options granted.

+ References

+ Details

Name:	ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of share options outstanding in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2019-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2019-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of share options forfeited in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2019-01-01
-Paragraph 45
-Subparagraph b
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_b_iii&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=gnft_OfficersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=gnft_EmployeesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SO1Et22017Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=gnft_EmployeesAndOfficersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOUS2017Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOUS1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SO1Et22016Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOUS2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOUS2016Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SO2018Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=gnft_SOUS2018Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Share-Based Compensation - Summary of Key Terms and Conditions of Share-Based Compensation Based on Stock Options (Details)	12 Months Ended
	Dec. 31, 2019 shares € / shares	Dec. 31, 2018 shares € / shares	Dec. 31, 2017 shares € / shares	Dec. 31, 2016 shares € / shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting	Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO	Oct. 18, 2019
Date of the CEO decision	Oct. 31, 2019
Excercise price \| € / shares	€ 12.32
Valuation method used	Black & Scholes
Expected dividends	0.00%
Expected volatility	40.00%
Risk-free interest rate	0.00%
SO \| Officers
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting	Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO	Jul. 18, 2019
Date of the CEO decision	Jul. 18, 2019
Total number of SO subscribed	15,130
Total number of SO voided	0
Total number of SO definitively vested	0
Total number of SO remaining	15,130
Excercise price \| € / shares	€ 13.99
Vesting period	From 07/18/2019 to 09/16/2022
Exercise period	From 09/17/2022 to 09/17/2029
Fair value \| € / shares	€ 4.59
Valuation method used	Monte Carlo
Price of the share at the time of allocation \| € / shares	€ 17.06
Expected dividends	0.00%
Expected volatility	40.16%
Risk-free interest rate	0.00%
Turnover rate	0.00%
SO \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting	Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO	Jul. 18, 2019
Date of the CEO decision	Jul. 18, 2019
Total number of SO subscribed	92,750
Total number of SO voided	1,780
Total number of SO definitively vested	0
Total number of SO remaining	90,970
Excercise price \| € / shares	€ 13.99
Vesting period	From 07/18/2019 to 09/16/2022
Exercise period	From 09/17/2022 to 09/17/2029
Fair value \| € / shares	€ 4.59
Valuation method used	Monte Carlo
Price of the share at the time of allocation \| € / shares	€ 17.06
Expected dividends	0.00%
Expected volatility	40.16%
Risk-free interest rate	0.00%
Turnover rate	0.00%
SO 1 et 2 2017 \| Employees and Officers
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting			Jun. 16, 2017
Date of the decision and delegation of the Board of Directors to the CEO			Nov. 21, 2017
Date of the CEO decision			Dec. 06, 2017
Total number of SO subscribed			96,250
Total number of SO voided			21,577
Total number of SO definitively vested			0
Total number of SO remaining			74,673
Excercise price \| € / shares			€ 17.91
Vesting period			From 12/06/2017 to 12/31/2020
Exercise period			From 01/01/2021to 12/31/2027
Fair value \| € / shares			€ 9.32
Valuation method used			Monte Carlo
Price of the share at the time of allocation \| € / shares			€ 21.95
Expected dividends			0.00%
Expected volatility			53.70%
Risk-free interest rate			0.00%
Turnover rate			15.00%
SO US 2017 \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting			Jun. 16, 2017
Date of the decision and delegation of the Board of Directors to the CEO			Nov. 21, 2017
Date of the CEO decision			Dec. 06, 2017
Total number of SO subscribed			13,000
Total number of SO voided			13,000
Total number of SO definitively vested			0
Total number of SO remaining			0
Excercise price \| € / shares			€ 22.54
Vesting period			From 12/06/2017 to 12/31/2020
Exercise period			From 01/01/2021to 12/31/2027
Fair value \| € / shares			€ 9.32
Valuation method used			Monte Carlo
Price of the share at the time of allocation \| € / shares			€ 21.95
Expected dividends			0.00%
Expected volatility			53.70%
Risk-free interest rate			0.00%
Turnover rate			15.00%
SO US 1 \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting	Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO	Jul. 18, 2019
Date of the CEO decision	Jul. 18, 2019
Total number of SO subscribed	30,620
Total number of SO voided	0
Total number of SO definitively vested	0
Total number of SO remaining	30,620
Excercise price \| € / shares	€ 16.9
Vesting period	From 07/18/2019 to 09/16/2022
Exercise period	From 09/17/2022 to 09/17/2029
Fair value \| € / shares	€ 3.67
Valuation method used	Monte Carlo
Price of the share at the time of allocation \| € / shares	€ 17.06
Expected dividends	0.00%
Expected volatility	40.16%
Risk-free interest rate	0.00%
Turnover rate	0.00%
SO US 2016 \| Employees and Officers
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting				Jun. 21, 2016
Date of the Management Board meeting				Dec. 15, 2016
Total number of SO subscribed				62,875
Total number of SO voided				13,169
Total number of SO definitively vested				49,706
Total number of SO remaining				0
Excercise price \| € / shares				€ 15.79
Vesting period				From 12/15/2016 to 12/15/2019
Exercise period				From 12/16/2019 to 12/16/2026
Fair value \| € / shares				€ 10.3
Valuation method used				Monte Carlo
Price of the share at the time of allocation \| € / shares				€ 20.79
Expected dividends				0.00%
Expected volatility				63.00%
Risk-free interest rate				0.00%
Turnover rate				15.00%
SO US 2 \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting	Nov. 27, 2019
Date of the decision and delegation of the Board of Directors to the CEO	Nov. 27, 2019
Date of the CEO decision	Nov. 27, 2019
Total number of SO subscribed	13,350
Total number of SO voided	0
Total number of SO definitively vested	0
Total number of SO remaining	13,350
Excercise price \| € / shares	€ 14.31
Vesting period	From 11/27/2019 to 01/16/2023
Exercise period	From 01/17/2023 to 01/17/2030
Fair value \| € / shares	€ 3.23
Valuation method used	Monte Carlo
Price of the share at the time of allocation \| € / shares	€ 14.5
Expected dividends	0.00%
Expected volatility	40.00%
Risk-free interest rate	0.00%
Turnover rate	0.00%
SO US 2016 \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting				Jun. 21, 2016
Date of the Management Board meeting				Dec. 15, 2016
Total number of SO subscribed				10,500
Total number of SO voided				10,500
Total number of SO definitively vested				0
Total number of SO remaining				0
Excercise price \| € / shares				€ 21.12
Vesting period				From 12/15/2016 to 12/15/2019
Exercise period				From 12/16/2019 to 12/16/2026
Fair value \| € / shares				€ 8.52
Valuation method used				Monte Carlo
Price of the share at the time of allocation \| € / shares				€ 20.79
Expected dividends				0.00%
Expected volatility				63.00%
Risk-free interest rate				0.00%
Turnover rate				15.00%
SO 2018 \| Employees and Officers
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting		Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO		Nov. 07, 2018
Date of the CEO decision		Nov. 07, 2018
Total number of SO subscribed		122,000
Total number of SO voided		2,000
Total number of SO definitively vested		0
Total number of SO remaining		120,000
Excercise price \| € / shares		€ 16.00
Vesting period		From 11/07/2018 to 12/31/2021
Exercise period		From 01/01/2022 to 12/31/2028
Fair value \| € / shares		€ 9.32
Valuation method used		Monte Carlo
Price of the share at the time of allocation \| € / shares		€ 22.12
Expected dividends		0.00%
Expected volatility		44.07%
Risk-free interest rate		0.00%
Turnover rate		15.00%
SO US 2018 \| Employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Date of the Shareholders meeting		Jun. 15, 2018
Date of the decision and delegation of the Board of Directors to the CEO		Nov. 07, 2018
Date of the CEO decision		Nov. 07, 2018
Total number of SO subscribed		17,500
Total number of SO voided		3,000
Total number of SO definitively vested		0
Total number of SO remaining		14,500
Excercise price \| € / shares		€ 21.65
Vesting period		From 11/07/2018 to 12/31/2021
Exercise period		From 01/01/2022 to 12/31/2028
Fair value \| € / shares		€ 6.9
Valuation method used		Monte Carlo
Price of the share at the time of allocation \| € / shares		€ 22.12
Expected dividends		0.00%
Expected volatility		44.07%
Risk-free interest rate		0.00%
Turnover rate		15.00%